Andrew Prideaux, Ph.D.

Dr. Andrew Prideaux was a post-doctoral fellow in the Radionuclide Therapy and Dosimetry Research Lab, Division of Nuclear Medicine in the Russell H. Morgan Dept of Radiology and Radiological Science at The Johns Hopkins University, School of Medicine between the summers of 2005 and 2008. He received his Bachelor's degree in Physics from Fort Hays State University and both his M.S. and  Ph.D. in Physics from The University of Missouri-Rolla.

Dr. Prideaux has a background in Atomic, Molecular and Optical Physics.  His empahasis has been in scattering theory using a quantum mechanical approach.  The title of his Ph.D. is " The Importance of Correlation Effects in Electron Impact Ionization of Heavy Noble Gasses".  Andrew has used this understanding of particle scattering to enhance accelerator design, as well as probe our understanding of basic particle science.

RESEARCH

Dr. Prideaux’s research included development of 3D-RD, a 3-D voxel-based patient-specific dosimetry software package, which uses anatomic information from CT and radionuclide biodistribution from SPECT or PET to generate images of the spatial distribution of absorbed dose and units which take radio-sensitivity into account.  He also supporte the radiopharmaceutical dosimetry section by providing absorbed dose estimates for thyroid cancer and Non-Hodgkin's Lymphoma patients.  He also participated in a project to extract quantitative activity concentration for alpha-particle dosimetry from microSPECT images of labeled Herceptin biodistribution in an transgenic model of breast cancer.

Following his tenure at Hopkins Dr. Prideaux left to work with Hermes Medical Solutions as a Clinical Applications Specialist.